Immunocore Holdings (IMCR) Leases (2022 - 2025)
Immunocore Holdings (IMCR) has disclosed Leases for 4 consecutive years, with $38.8 million as the latest value for Q4 2025.
- Quarterly Leases rose 3.03% to $38.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.8 million through Dec 2025, up 3.03% year-over-year, with the annual reading at $38.8 million for FY2025, 3.03% up from the prior year.
- Leases hit $38.8 million in Q4 2025 for Immunocore Holdings, down from $39.4 million in the prior quarter.
- In the past five years, Leases ranged from a high of $39.7 million in Q3 2024 to a low of $30.9 million in Q4 2022.
- Historically, Leases has averaged $36.3 million across 4 years, with a median of $37.9 million in 2024.
- Biggest YoY gain for Leases was 21.56% in 2025; the steepest drop was 0.69% in 2025.
- Year by year, Leases stood at $30.9 million in 2022, then increased by 8.32% to $33.5 million in 2023, then rose by 12.3% to $37.6 million in 2024, then rose by 3.03% to $38.8 million in 2025.
- Business Quant data shows Leases for IMCR at $38.8 million in Q4 2025, $39.4 million in Q3 2025, and $39.4 million in Q2 2025.